38.125 USD
+0.3 (+0.81%)
Taking everything into account, IBEX scores 7 out of 10 in our fundamental rating. IBEX was compared to 88 industry peers in the IT Services industry. Both the health and profitability get an excellent rating, making IBEX a very profitable company, without any liquidiy or solvency issues. IBEX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make IBEX suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
IBEX had positive earnings in the past year.
In the past year IBEX had a positive cash flow from operations.
Each year in the past 5 years IBEX has been profitable.
In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
IBEX has a Return On Assets of 14.58%. This is amongst the best in the industry. IBEX outperforms 93.18% of its industry peers.
IBEX has a Return On Equity of 28.81%. This is amongst the best in the industry. IBEX outperforms 92.05% of its industry peers.
Looking at the Return On Invested Capital, with a value of 21.63%, IBEX belongs to the top of the industry, outperforming 94.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROIC | 21.63% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 7.14%, IBEX is doing good in the industry, outperforming 73.86% of the companies in the same industry.
In the last couple of years the Profit Margin of IBEX has grown nicely.
IBEX has a better Operating Margin (9.18%) than 68.18% of its industry peers.
IBEX's Operating Margin has improved in the last couple of years.
IBEX has a Gross Margin of 30.62%. This is comparable to the rest of the industry: IBEX outperforms 44.32% of its industry peers.
In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
IBEX has an Altman-Z score of 5.32. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
IBEX has a better Altman-Z score (5.32) than 77.27% of its industry peers.
The Debt to FCF ratio of IBEX is 0.05, which is an excellent value as it means it would take IBEX, only 0.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.05, IBEX belongs to the top of the industry, outperforming 93.18% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that IBEX is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.01, IBEX belongs to the best of the industry, outperforming 84.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 5.32 |
ROIC/WACC2.3
WACC9.41%
2.3 Liquidity
A Current Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
IBEX's Current ratio of 1.82 is in line compared to the rest of the industry. IBEX outperforms 56.82% of its industry peers.
IBEX has a Quick Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IBEX (1.82) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 41.96% over the past year.
IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.04% yearly.
The Revenue has grown by 12.86% in the past year. This is quite good.
IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
3.2 Future
The Earnings Per Share is expected to grow by 13.72% on average over the next years. This is quite good.
Based on estimates for the next years, IBEX will show a quite strong growth in Revenue. The Revenue will grow by 9.19% on average per year.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.99 indicates a reasonable valuation of IBEX.
Based on the Price/Earnings ratio, IBEX is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
IBEX is valuated cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.53, the valuation of IBEX can be described as very reasonable.
89.77% of the companies in the same industry are more expensive than IBEX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of IBEX to the average of the S&P500 Index (23.57), we can say IBEX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.99 | ||
| Fwd PE | 10.53 |
4.2 Price Multiples
IBEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBEX is cheaper than 89.77% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBEX indicates a somewhat cheap valuation: IBEX is cheaper than 70.45% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.46 | ||
| EV/EBITDA | 6.93 |
4.3 Compensation for Growth
IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IBEX may justify a higher PE ratio.
IBEX's earnings are expected to grow with 13.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)0.29
EPS Next 2Y13.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:IBEX (1/8/2026, 1:39:56 PM)
38.125
+0.3 (+0.81%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.08%
Inst Owner Change0%
Ins Owners2.8%
Ins Owner Change0.29%
Market Cap513.54M
Revenue(TTM)579.74M
Net Income(TTM)41.38M
Analysts45.71
Price Target41.82 (9.69%)
Short Float %1.15%
Short Ratio1.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.95%
Min EPS beat(2)20.05%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)16.83%
Min EPS beat(4)10.89%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)12.58%
EPS beat(12)10
Avg EPS beat(12)14.59%
EPS beat(16)12
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)5.51%
Min Revenue beat(2)2.5%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)2.45%
Max Revenue beat(4)8.52%
Revenue beat(8)5
Avg Revenue beat(8)1.79%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)6.49%
PT rev (3m)6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.26%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.99 | ||
| Fwd PE | 10.53 | ||
| P/S | 0.89 | ||
| P/FCF | 16.46 | ||
| P/OCF | 9.59 | ||
| P/B | 3.58 | ||
| P/tB | 3.9 | ||
| EV/EBITDA | 6.93 |
EPS(TTM)3.18
EY8.34%
EPS(NY)3.62
Fwd EY9.5%
FCF(TTM)2.32
FCFY6.07%
OCF(TTM)3.98
OCFY10.43%
SpS43.04
BVpS10.66
TBVpS9.78
PEG (NY)0.52
PEG (5Y)0.29
Graham Number27.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROCE | 26.64% | ||
| ROIC | 21.63% | ||
| ROICexc | 24.4% | ||
| ROICexgc | 26.15% | ||
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% | ||
| FCFM | 5.38% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 129.83% | ||
| Cap/Sales | 3.86% | ||
| Interest Coverage | 31.53 | ||
| Cash Conversion | 76.01% | ||
| Profit Quality | 75.39% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.32 |
F-Score8
WACC9.41%
ROIC/WACC2.3
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.86%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.48%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.26%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y19.11%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
What is the valuation status for IBEX stock?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
What is the valuation of IBEX LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 11.99 and the Price/Book (PB) ratio is 3.58.
Is the dividend of IBEX LTD sustainable?
The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.